MARISA CHANG: Open Payments
NPI 1730348269 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,360 in 180 payments from 27 companies in 2025. Trend: 2023 $4,179 · 2024 $4,206 · 2025 $9,360
Long term medical supply or device loan: $4,768Food & beverage: $4,592
| Company | Payments | Amount |
|---|---|---|
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 2 | $4,835 |
| ABBVIE INC. | 48 | $1,279 |
| Lundbeck LLC | 24 | $584 |
| UCB, Inc. | 14 | $420 |
| PFIZER INC. | 21 | $392 |
| Axsome Therapeutics, Inc. | 14 | $343 |
| Merz Pharmaceuticals, LLC | 8 | $285 |
| ACADIA Pharmaceuticals Inc | 8 | $149 |
| Ipsen Biopharmaceuticals, Inc | 4 | $134 |
| JAZZ PHARMACEUTICALS INC. | 4 | $114 |
Products named: RS-4i Plus with Intersperse, QULIPTA, VYEPTI, UBRELVY, Symbravo, NURTEC ODT, Xeomin, VRAYLAR.
Industry payments across CA — which companies pay providers there.
